Literature DB >> 2277762

A simple high pressure liquid chromatographic method for the determination of fluorouracil to monitor patients on regional infusion for hepatic metastases.

C H Koks1, H J Van der Kam, J R Brouwers.   

Abstract

A rapid and sensitive high pressure liquid chromatographic method has been developed for the routine monitoring in serum of the antineoplastic agent fluorouracil, during continuous intraportal administration. Serum spiked with internal standard, bromouracil, was gently shaken for 10 min with ethylacetate at an acidic pH. The evaporated extract was dissolved in the mobile phase containing potassium phosphate buffer. Assays were performed at ambient temperature on a Chrompack LiChrosorb RP 18 column (2 X 100 X 3.0 mm) equipped with a guard column. The retention time of fluorouracil was 2-6 min. The calibration curve was linear from 25 to 2,000 ng/ml. The coefficient of variation was less than or equal to 1.6% for within-run precision and less than or equal to 2.9% for day-to-day precision. The mean recovery of fluorouracil was 57%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2277762     DOI: 10.1007/bf01970157

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  11 in total

1.  THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.

Authors:  B CLARKSON; A O'CONNOR; L WINSTON; D HUTCHISON
Journal:  Clin Pharmacol Ther       Date:  1964 Sep-Oct       Impact factor: 6.875

2.  GLC assay for 5-fluorouracil in biological fluids.

Authors:  J L Cohen; P B Brennan
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

3.  Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma.

Authors:  N Christophidis; G Mihaly; F Vajda; W Louis
Journal:  Clin Chem       Date:  1979-01       Impact factor: 8.327

4.  Adsorption of fluorouracil on glass surfaces.

Authors:  O Driessen; D de Vos; P J Timmermans
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

5.  GLC determination of fluorouracil.

Authors:  K V Rao; K Killion; Y Tanrikut
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

6.  Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro.

Authors:  P M Calabro-Jones; J E Byfield; J F Ward; T R Sharp
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Phase I and pharmacologic study of 72-hour infused 5-fluorouracil in man.

Authors:  J E Byfield; S S Frankel; C L Hornbeck; T R Sharp; F B Callipari; R A Floyd
Journal:  Am J Clin Oncol       Date:  1985-10       Impact factor: 2.339

8.  Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer.

Authors:  A Thyss; G Milano; N Renée; J Vallicioni; M Schneider; F Demard
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Reversed-phase ion-pair analysis of 5-fluorouracil in pig bile, liver homogenate, plasma and urine after administration by isolated liver perfusion.

Authors:  J A Bierman; H Lingeman; H J Reeuwijk; E A de Bruijn; U R Tjaden; J van der Greef
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

10.  High-performance liquid chromatography of 5-fluorouracil after derivatization with 4-bromomethyl-7-methoxycoumarin. Characterization of the derivative and the use of column switching for the improvement of resolution and the enhancement of sensitivity.

Authors:  C G Kindberg; M Slavik; C M Riley; J F Stobaugh
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.